New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination

Abstract

Abstract The COVID‐19 mRNA vaccines not only provide remarkable protection but also have been characterized by an overall safe and well‐tolerated side effect profile. Herein, we discuss a rare but manageable cutaneous reaction to COVID vaccination in order to further characterize dermatologic reactions and stress the continued vaccination of eligible patients.

Keywords

• adverse reaction
• COVID‐19
• mRNA vaccine
• vitiligo